VolitionRx Limited Contract Liability (Deferred Revenue)
VolitionRx Limited (VNRX) had Contract Liability (Deferred Revenue) of $97.89 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2025-03-31
- 2024-12-31: Contract with Customer, Liability, Current $97.89K.
- 2024-09-30: Contract with Customer, Liability, Current $96.22K.
- 2024-06-30: Contract with Customer, Liability, Current $101.10K.
- 2023-12-31: Contract with Customer, Liability, Current $126.65K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2024-12-31 | $97.89K 10-K · filed 2025-03-31 |
| 2024-09-30 | $96.22K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $101.10K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $126.65K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |